{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:08:25Z","timestamp":1789571305187,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jconrel.2023.10.033","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:25:16Z","timestamp":1698747916000},"page":"246-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction"],"prefix":"10.1016","volume":"364","author":[{"given":"Amit","family":"Itzhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Eilon-Ashkenazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Shmidov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Lacham-Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Elyagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Etzion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Bitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smadar","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Etzion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.10.033_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldr018","article-title":"Cardiac cell therapy: where we\u2019ve been, where we are, and where we should be headed","author":"Malliaras","year":"2011","journal-title":"Br. Med. Bull."},{"issue":"16","key":"10.1016\/j.jconrel.2023.10.033_bb0010","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/j.biomaterials.2010.02.026","article-title":"The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model","volume":"31","author":"Ruvinov","year":"2010","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.jconrel.2023.10.033_bb0015","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/acs.biomac.7b00760","article-title":"Sustained release of a peptide-based matrix Metalloproteinase-2 inhibitor to attenuate adverse cardiac remodeling and improve cardiac function following myocardial infarction","volume":"18","author":"Fan","year":"2017","journal-title":"Biomacromolecules"},{"issue":"March","key":"10.1016\/j.jconrel.2023.10.033_bb0020","article-title":"Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition","volume":"13","author":"Purcell","year":"2014","journal-title":"Nat. Mater."},{"issue":"223","key":"10.1016\/j.jconrel.2023.10.033_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007244","article-title":"Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction","volume":"6","author":"Eckhouse","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2023.10.033_bb0030","doi-asserted-by":"crossref","first-page":"H814","DOI":"10.1152\/ajpheart.00076.2018","article-title":"Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling","volume":"315","author":"Purcell","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"July","key":"10.1016\/j.jconrel.2023.10.033_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2018.07.004","article-title":"Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart","volume":"285","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"issue":"November 2020","key":"10.1016\/j.jconrel.2023.10.033_bb0040","doi-asserted-by":"crossref","first-page":"100957","DOI":"10.1016\/j.mtla.2020.100957","article-title":"An injectable hydrogel to reverse the adverse microenvironment of diabetic infarcted heart","volume":"vol. 15","author":"Chen","year":"2021","journal-title":"Materialia"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0045","first-page":"1","article-title":"Strategies using gelatin microparticles for regenerative therapy and drug screening applications","author":"Nii","year":"2021","journal-title":"Mol. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2023.10.033_bb0050","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/j.2040-4603.2015.tb00658.x","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.10.033_bb0055","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2023.10.033_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-018-0668-z","article-title":"Molecular imaging of cardiac remodelling after myocardial infarction","volume":"113","author":"Curley","year":"2018","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and National Burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.10.033_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","article-title":"Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation","volume":"139","author":"Halade","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"17","key":"10.1016\/j.jconrel.2023.10.033_bb0085","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.103.17.2181","article-title":"Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia\/reperfusion","volume":"103","author":"Lindsey","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0090","doi-asserted-by":"crossref","first-page":"H190","DOI":"10.1152\/ajpheart.00243.2016","article-title":"MMP-9 signaling in the left ventricle following myocardial infarction","volume":"311","author":"Iyer","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"17","key":"10.1016\/j.jconrel.2023.10.033_bb0095","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/01.CIR.98.17.1728","article-title":"Differential expression of tissue inhibitors of metalloproteinases in the failing human heart","volume":"98","author":"Li","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1755-5922.2010.00207.x","article-title":"Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction","volume":"30","author":"Lindsey","year":"2012","journal-title":"Cardiovasc. Ther."},{"issue":"10","key":"10.1016\/j.jconrel.2023.10.033_bb0105","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.105.600353","article-title":"Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling","volume":"114","author":"Webb","year":"2006","journal-title":"Circulation"},{"issue":"43","key":"10.1016\/j.jconrel.2023.10.033_bb0110","doi-asserted-by":"crossref","first-page":"29893","DOI":"10.1074\/jbc.M109.028449","article-title":"Simultaneous transforming growth factor \u03b2-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart","volume":"284","author":"Kassiri","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.jconrel.2023.10.033_bb0115","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/01.CIR.0000091087.78630.79","article-title":"Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling","volume":"108","author":"Yarbrough","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jconrel.2023.10.033_bb0120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.CIR.0000046449.36178.00","article-title":"Myocardial infarct expansion and matrix metalloproteinase inhibition","volume":"107","author":"Mukherjee","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI8768","article-title":"Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction","volume":"106","author":"Ducharme","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.jconrel.2023.10.033_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.jconrel.2023.10.033_bb0135","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/01.CIR.102.16.1944","article-title":"A matrix metalloproteinase induction\/activation system exists in the human left ventricular myocardium and is upregulated in heart failure","volume":"102","author":"Spinale","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction. Results of the PREMIER (prevention of myocardial infarction early remodeling) trial","volume":"48","author":"Hudson","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.jconrel.2023.10.033_bb0145","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS malignancy consortium study","volume":"24","author":"Dezube","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0150","first-page":"383","article-title":"Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction","volume":"no. Mi","author":"Tessone","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2023.10.033_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mabi.201800079","article-title":"Injectable hydrogels for cardiac tissue engineering","volume":"18","author":"Pe\u00f1a","year":"2018","journal-title":"Macromol. Biosci."},{"issue":"34","key":"10.1016\/j.jconrel.2023.10.033_bb0160","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/eurheartj\/ehv259","article-title":"A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)","volume":"36","author":"Anker","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.copbio.2020.08.008","article-title":"Engineered biomaterials for heart disease","volume":"66","author":"Stapleton","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"issue":"June","key":"10.1016\/j.jconrel.2023.10.033_bb0170","first-page":"1","article-title":"Nanoparticle-mediated drug delivery for treatment of ischemic heart disease","volume":"8","author":"Fan","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.10.033_bb0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acs.nanolett.5b03598","article-title":"Spontaneous Coassembly of biologically active nanoparticles via affinity binding of heparin-binding proteins to alginate-sulfate","volume":"16","author":"Ruvinov","year":"2016","journal-title":"Nano Lett."},{"issue":"22","key":"10.1016\/j.jconrel.2023.10.033_bb0180","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1016\/j.biomaterials.2008.04.025","article-title":"The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins","volume":"29","author":"Freeman","year":"2008","journal-title":"Biomaterials"},{"issue":"June","key":"10.1016\/j.jconrel.2023.10.033_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.omtn.2019.03.006","article-title":"Co-assembled Ca2+ alginate-sulfate nanoparticles for intracellular plasmid DNA delivery","volume":"16","author":"Goldshtein","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2015.04.021","article-title":"Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook- from ocean algae to patient bedside","volume":"96","author":"Ruvinov","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2023.10.033_bb0195","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2010.11.008","article-title":"Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration","volume":"32","author":"Sapir","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0200","first-page":"21","article-title":"Molecular modeling of protein-glycosaminoglycan interactions","volume":"9","author":"Cardin","year":"1989","journal-title":"Arterioscler. An Off. J. Am. Hear. Assoc."},{"issue":"2","key":"10.1016\/j.jconrel.2023.10.033_bb0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2010.08.097","article-title":"The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction","volume":"32","author":"Ruvinov","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0210","first-page":"1","article-title":"Protein based nanostructures for drug delivery","volume":"2018","author":"Verma","year":"2018","journal-title":"J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2023.10.033_bb0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1042\/BCJ20200628","article-title":"Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy","volume":"478","author":"Yosef","year":"2021","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.jconrel.2023.10.033_bb0220","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1074\/jbc.M116.756718","article-title":"Development of high affinity and high specificity inhibitors of matrix metalloproteinase 14 through computational design and directed evolution","volume":"292","author":"Arkadash","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.2582","article-title":"Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential","volume":"18","author":"Sela-Passwell","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-452-0_15","article-title":"Use of gel Zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures","volume":"814","author":"Frankowski","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063071","article-title":"Predicting proteolysis in complex proteomes using deep learning","author":"Ozols","year":"2021","journal-title":"Int. J. Mol. Sci. Artic."},{"issue":"6","key":"10.1016\/j.jconrel.2023.10.033_bb0240","first-page":"3315","article-title":"Synthesis and characterization of a biotin-alginate conjugate and its application in a biosensor construction","volume":"6","author":"Polyak","year":"2005","journal-title":"Biomacromolecules"},{"issue":"21","key":"10.1016\/j.jconrel.2023.10.033_bb0245","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1016\/j.jmb.2018.08.028","article-title":"Oligomerization and auto-methylation of the human lysine methyltransferase SETD6","volume":"430","author":"Weil","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.10.033_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0010-4655(82)90173-4","article-title":"A constrained regularization method for inverting data represented by linear algebraic or integral equations","volume":"27","author":"Provencher","year":"1982","journal-title":"Comput. Phys. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2023.10.033_bb0255","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1107\/S0021889809002222","article-title":"Irena: tool suite for modeling and analysis of small-angle scattering","volume":"42","author":"Ilavsky","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0146-3535(89)90023-3","article-title":"Small-angle scattering of X-rays","volume":"18, no. C","author":"Stuhrmann","year":"1989","journal-title":"Prog. Cryst. Growth Charact."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jconrel.2023.10.033_bb0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0169-409X(97)00125-7","article-title":"Protein release from gelatin matrices","volume":"31","author":"Tabata","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0280","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/IJN.S124938","article-title":"The role of surface charge in the desolvation process of gelatin: implications in nanoparticle synthesis and modulation of drug release","volume":"12","author":"Ahsan","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2023.10.033_bb0285","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/gels3040035","article-title":"Controlled release of vascular endothelial growth factor from heparin-functionalized gelatin type a and albumin hydrogels","volume":"3","author":"Claa\u00dfen","year":"2017","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2005.09.023","article-title":"Gelatin as a delivery vehicle for the controlled release of bioactive molecules","volume":"109","author":"Young","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0295","article-title":"Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing","volume":"no. 2018","author":"Ishihara","year":"2018","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.jconrel.2023.10.033_bb0300","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.febslet.2015.08.027","article-title":"A practical guide to small angle X-ray scattering (SAXS) of flexible and intrinsically disordered proteins","volume":"589","author":"Kikhney","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cplett.2011.11.049","article-title":"Effect of interparticle interactions on size determination of zirconia and silica based systems - a comparison of SAXS, DLS, BET, XRD and TEM","volume":"521","author":"Pabisch","year":"2012","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0310","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nimb.2014.11.049","article-title":"Combining SAXS and DLS for simultaneous measurements and time-resolved monitoring of nanoparticle synthesis","volume":"343","author":"Schwamberger","year":"2015","journal-title":"Nucl. Instruments Methods Phys. Res. Sect. B Beam Interact. with Mater. Atoms"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0315","series-title":"Scattering Methods and their Application in Colloid and Interface Science","author":"Glatter","year":"2018"},{"issue":"4","key":"10.1016\/j.jconrel.2023.10.033_bb0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/ed047p261","article-title":"Molecular volumes and the stokes-Einstein equation","volume":"47","author":"Edward","year":"1970","journal-title":"J. Chem. Educ."},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0325","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2007.04.009","article-title":"Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release","volume":"59","author":"Gan","year":"2007","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2023.10.033_bb0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(02)00136-0","article-title":"Precise control of PLG microsphere size provides enhanced control of drug release rate","volume":"82","author":"Berkland","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0335","first-page":"47","article-title":"Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2023.10.033_bb0340","article-title":"Progress in the application of sustained-release drug microspheres in tissue engineering","volume":"16, no. July","author":"Ruan","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"9","key":"10.1016\/j.jconrel.2023.10.033_bb0345","article-title":"Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: a real world study","volume":"96","author":"Perelshtein Brezinov","year":"2017","journal-title":"Med. (United States)"},{"issue":"9","key":"10.1016\/j.jconrel.2023.10.033_bb0350","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","article-title":"Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction","volume":"7","author":"Aimo","year":"2019","journal-title":"JACC Hear. Fail."},{"issue":"22","key":"10.1016\/j.jconrel.2023.10.033_bb0355","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000068375.40887.FA","article-title":"Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling","volume":"107","author":"Wilson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2023.10.033_bb0360","series-title":"Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures","first-page":"2850","author":"Sundstr\u00f6m","year":"2004"},{"issue":"3","key":"10.1016\/j.jconrel.2023.10.033_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0193482","article-title":"The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system","volume":"13","author":"Hogwood","year":"2018","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.jconrel.2023.10.033_bb0370","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923006831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923006831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:50:22Z","timestamp":1759164622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923006831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":74,"alternative-id":["S0168365923006831"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.033","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}